...
tecx-img

Tectonic Therapeutic, Inc., Common Stock

TECX

NMQ

$47.44

+$3.38

(7.67%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$265.07M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
227.80K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0 L
$53.34 H
$47.44

About Tectonic Therapeutic, Inc., Common Stock

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTECXSectorS&P500
1-Week Return4.65%-2.12%-3%
1-Month Return7.74%-3.42%-0.73%
3-Month Return136.25%-11.13%2.87%
6-Month Return3953233.33%-5.74%7.17%
1-Year Return3953233.33%3.97%25.31%
3-Year Return1976566.67%1.05%28.38%
5-Year Return3953233.33%34.37%81.89%
10-Year Return3953233.33%97.88%183.27%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue1.21M1.40M4.17M617.00K[{"date":"2020-12-31","value":28.97,"profit":true},{"date":"2021-12-31","value":33.58,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.81,"profit":true}]
Gross Profit(1.21M)(1.40M)(4.17M)(617.00K)[{"date":"2020-12-31","value":-120700000,"profit":false},{"date":"2021-12-31","value":-139900000,"profit":false},{"date":"2022-12-31","value":-416600000,"profit":false},{"date":"2023-12-31","value":-61700000,"profit":false}]
Gross Margin----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses119.02M117.44M101.27M44.65M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.67,"profit":true},{"date":"2022-12-31","value":85.08,"profit":true},{"date":"2023-12-31","value":37.51,"profit":true}]
Operating Income(120.23M)(118.84M)(105.43M)(44.65M)[{"date":"2020-12-31","value":-12022800000,"profit":false},{"date":"2021-12-31","value":-11884100000,"profit":false},{"date":"2022-12-31","value":-10543400000,"profit":false},{"date":"2023-12-31","value":-4464800000,"profit":false}]
Total Non-Operating Income/Expense-(103.96M)(73.06M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-10396100000,"profit":false},{"date":"2022-12-31","value":-7305500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(119.71M)(119.13M)(105.89M)(42.82M)[{"date":"2020-12-31","value":-11971200000,"profit":false},{"date":"2021-12-31","value":-11912600000,"profit":false},{"date":"2022-12-31","value":-10589000000,"profit":false},{"date":"2023-12-31","value":-4282300000,"profit":false}]
Income Taxes---377.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(8.93M)(32.18M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-892700000,"profit":false},{"date":"2022-12-31","value":-3218000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(119.71M)(119.13M)(105.89M)(42.82M)[{"date":"2020-12-31","value":-11971200000,"profit":false},{"date":"2021-12-31","value":-11912600000,"profit":false},{"date":"2022-12-31","value":-10589000000,"profit":false},{"date":"2023-12-31","value":-4282300000,"profit":false}]
EPS (Diluted)(39.71)(25.23)(29.05)3.81[{"date":"2020-12-31","value":-1043.61,"profit":false},{"date":"2021-12-31","value":-662.93,"profit":false},{"date":"2022-12-31","value":-763.55,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TECX
Cash Ratio 9.19
Current Ratio 9.39

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TECX
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TECX
Debt Ratio Lower is generally better. Negative is bad. 0.11
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.89

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TECX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.59
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Tectonic Therapeutic, Inc. share price today?

Tectonic Therapeutic, Inc. (TECX) share price today is $47.44

Can Indians buy Tectonic Therapeutic, Inc. shares?

Yes, Indians can buy shares of Tectonic Therapeutic, Inc. (TECX) on Vested. To buy Tectonic Therapeutic, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TECX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tectonic Therapeutic, Inc. be purchased?

Yes, you can purchase fractional shares of Tectonic Therapeutic, Inc. (TECX) via the Vested app. You can start investing in Tectonic Therapeutic, Inc. (TECX) with a minimum investment of $1.

How to invest in Tectonic Therapeutic, Inc. shares from India?

You can invest in shares of Tectonic Therapeutic, Inc. (TECX) via Vested in three simple steps:

  • Click on Sign Up or Invest in TECX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tectonic Therapeutic, Inc. shares
What is Tectonic Therapeutic, Inc. 52-week high and low stock price?

The 52-week high price of Tectonic Therapeutic, Inc. (TECX) is $53.34. The 52-week low price of Tectonic Therapeutic, Inc. (TECX) is $0.

What is Tectonic Therapeutic, Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tectonic Therapeutic, Inc. (TECX) is

What is Tectonic Therapeutic, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tectonic Therapeutic, Inc. (TECX) is 1.59

What is Tectonic Therapeutic, Inc. dividend yield?

The dividend yield of Tectonic Therapeutic, Inc. (TECX) is 0.00%

What is the Market Cap of Tectonic Therapeutic, Inc.?

The market capitalization of Tectonic Therapeutic, Inc. (TECX) is $265.07M

What is Tectonic Therapeutic, Inc.’s stock symbol?

The stock symbol (or ticker) of Tectonic Therapeutic, Inc. is TECX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top